Lupin Launches Generic Minocycline Hydrochloride ER Tablets USP

Pharma major Lupin announced the launch of Minocycline Hydrochloride Extended-Release Tablets USP 55mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Minocycline Hydrochloride ER Tablets USP 55mg is a generic version of Medicis Pharmaceutical Corporation’s Solodyn 55 mg. It is indicated to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Minocycline Hydrochloride ER Tablets USP, 55 mg (RLD: Solodyn) had annual sales of approximately USD 76.8 million in the US (IQVIA MAT December 2018). – Medical Buyer Bureau